B6Dnk;B6N-Pknox1Gt(EUCJ0079d10)Hmgu/Ieg

Status

Available to order

EMMA IDEM:04608
International strain nameB6Dnk;B6N-Pknox1Gt(EUCJ0079d10)Hmgu/Ieg
Alternative nameEUCJ0079_D10
Strain typeGene-trap
Allele/Transgene symbolPknox1Gt(EUCJ0079d10)Hmgu
Gene/Transgene symbolPknox1
DisclaimerPlease note that for EUCOMM and KOMP-CSD mice supplied to the scientific community by INFRAFRONTIER/EMMA:
  1. We can not guarantee a null mutation for Knock-out first alleles (tm1a alleles, see http://www.mousephenotype.org/about-ikmc/targeting-strategies) as the critical exon has not been deleted.
  2. That the structure of the targeted mutation in the ES cells obtained from EUCOMM/KOMP to generate EUCOMM/KOMP mice is not verified by INFRAFRONTIER/EMMA. It is recommended that the recipient confirms the mutation structure.
  3. No check for determining the copy number of the targeting construct in ES cells obtained from EUCOMM/KOMP is done by INFRAFRONTIER/EMMA.
  4. The level of quality control before mice are released is to confirm the individual mouse genotype by short range PCR.

Information from provider

Provider Helmholtz Zentrum Muenchen - German Research Center for Environmental Health (GmbH)
Provider affiliationInstitute of Experimental Genetics, Helmholtz Zentrum Muenchen - German Research Center for Environmental Health (GmbH)
Genetic informationThis mouse line originates from EUCOMM ES clone EUCJ0079_D10. For further details on the construction of this clone see the page at HTGT. Removal of the targeting cassette using Flp recombinase is required to convert the targeted into a conditional allele. Click here for more information on EUCOMM final vectors.
ReferencesNone available

Information from EMMA

Archiving centreHelmholtz Zentrum Muenchen - German Research Center for Environmental Health (GmbH), Oberschleißheim, Germany
Animals used for archivingheterozygous C57BL/6Dnk, wild-type C57BL/6Dnk
Stage of embryos2-cell

Disease and phenotype information

IMPC phenotypes (allele matching)
  • abnormal urination / IMPC
  • decreased circulating triglyceride level / IMPC
  • decreased hemoglobin content / IMPC
  • decreased B cell number / IMPC
  • decreased T cell number / IMPC
  • decreased mean corpuscular hemoglobin concentration / IMPC
  • decreased mature B cell number / IMPC
  • decreased IgG1 level / IMPC
  • preweaning lethality, complete penetrance / IMPC
IMPC phenotypes (gene matching)
  • decreased mean corpuscular hemoglobin concentration / IMPC
  • abnormal urination / IMPC
  • decreased IgG1 level / IMPC
  • decreased hemoglobin content / IMPC
  • decreased mature B cell number / IMPC
  • preweaning lethality, complete penetrance / IMPC
  • decreased B cell number / IMPC
  • decreased T cell number / IMPC
  • decreased circulating triglyceride level / IMPC
MGI phenotypes (allele matching)
  • no phenotypic analysis / MGI
MGI phenotypes (gene matching)
  • decreased hematocrit / MGI
  • abnormal erythropoiesis / MGI
  • abnormal liver development / MGI
  • decreased body weight / MGI
  • abnormal eye development / MGI
  • small lens / MGI
  • anemia / MGI
  • absent mesoderm / MGI
  • failure of primitive streak formation / MGI
  • decreased embryo size / MGI
  • edema / MGI
  • thymus hypoplasia / MGI
  • hemorrhage / MGI
  • abnormal embryonic tissue morphology / MGI
  • abnormal extraembryonic tissue morphology / MGI
  • abnormal eye morphology / MGI
  • abnormal pluripotent precursor cell morphology / MGI
  • abnormal blood cell morphology/development / MGI
  • no phenotypic analysis / MGI
  • pallor / MGI
  • embryonic growth retardation / MGI
  • abnormal prenatal growth/weight/body size / MGI
  • decreased fetal size / MGI
  • increased double-negative T cell number / MGI
  • abnormal retinal pigment epithelium morphology / MGI
  • decreased percent body fat/body weight / MGI
  • decreased angiogenesis / MGI
  • abnormal retinal neuronal layer morphology / MGI
  • increased T cell apoptosis / MGI
  • decreased single-positive T cell number / MGI
  • decreased erythroid progenitor cell number / MGI
  • increased nucleated erythrocyte cell number / MGI
  • decreased birth body size / MGI
  • perinatal lethality, complete penetrance / MGI
  • embryonic lethality, complete penetrance / MGI
  • embryonic lethality between implantation and somite formation, complete penetrance / MGI
  • lethality throughout fetal growth and development, complete penetrance / MGI
  • abnormal visceral endoderm morphology / MGI
  • absent anterior visceral endoderm / MGI

Information on how we integrate external resources can be found here

Order

Availabilities

Requesting frozen sperm or embryos is generally advisable wherever possible, in order to minimise the shipment of live mice.

  • Frozen embryos. Delivered in 4 weeks (after paperwork in place). €1740*
  • Rederivation of mice from frozen stock, delivery time available upon request . €3880*

Due to the dynamic nature of our processes strain availability may change at short notice. The local repository manager will advise you in these circumstances.

* In addition users have to cover all the shipping costs (including the cost for returning dry-shippers, where applicable).

More details on pricing and delivery times

Practical information

Genotyping protocol

Example health report
(Current health report will be provided later)

Material Transfer Agreement (MTA)
Distribution of this strain is subject to a provider MTA. Both signing of the MTA and submission of the online EMMA Mutant Request Form are required before material can be shipped.

EMMA conditions
Legally binding conditions for the transfer

Other EMMA strains

Not found what you were looking for? Search here for other strains available from EMMA.


Search
INFRAFRONTIER® and European Mouse Mutant Archive - EMMA® are registered trademarks at the European Union Intellectual Property Office (EUIPO).